Brilliant Violet 510a,,cents anti-human CD8 [SK1] and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0485368
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $272.25
About this award
The University of Virginia awarded a contract to BioLegend Inc. on September 28, 2026, for the provision of specialized laboratory reagents. The contract, identified as A207_PO-0485368, is valued at $272.00 and involves the delivery of two distinct fluorescent antibody products to Selin Ustel at the University of Virginia's facilities in Virginia.
The line items under this contract consist of two monoclonal antibody reagents commonly used in flow cytometry applications. The first item is Brilliant Violet 510a conjugated anti-human CD8 [SK1] antibody, priced at $99.00 per unit with a quantity of one. The second item is Brilliant Violet 605a conjugated Streptavidin, priced at $173.25 per unit with a quantity of one. These reagents are standard research tools used in immunological and cell analysis procedures within academic research settings.
Line items
| Item | Total |
|---|---|
| Brilliant Violet 510a,,cents anti-human CD8 [SK1] | $99.00 |
| Brilliant Violet 605a,,cents Streptavidin | $173.25 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0485368?
Contract A207_PO-0485368 was awarded to BIOLEGEND INC. by University of Virginia on September 28, 2026.
How much is contract A207_PO-0485368 worth?
Its cumulative value is $272.25.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award